Skip to content
NEWSnet Monterey
    • Homepage
SpyGlass Pharma Appoints Shannon Treviño as General Counsel

Author: SpyGlass Pharma, Inc.

Posted Date:

June 15, 2026
  • SpyGlass Pharma Appoints Shannon Treviño as General Counsel

    SpyGlass Pharma, Inc.
    June 15, 2026
  • SpyGlass Pharma Appoints Mike Pinder as Vice President, Marketing

    SpyGlass Pharma, Inc.
    June 2, 2026
  • SpyGlass Pharma to Participate in Upcoming Investor Conferences

    SpyGlass Pharma, Inc.
    May 21, 2026
  • SpyGlass Pharma Announces New Add-on Category III CPT Code for Its Innovative BIM-IOL System

    SpyGlass Pharma, Inc.
    May 18, 2026
  • SpyGlass Pharma Reports First Quarter 2026 Financial Results and Provides Corporate Updates

    SpyGlass Pharma, Inc.
    May 14, 2026
  • SpyGlass Pharma Announces Positive Topline 12-Month Phase 1/2 Trial Results for Its Innovative BIM-IOL System

    SpyGlass Pharma, Inc.
    March 9, 2026
  • SpyGlass Pharma to Participate in the Jefferies Biotech on the Beach Summit

    SpyGlass Pharma, Inc.
    March 4, 2026
  • SpyGlass Pharma Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares

    SpyGlass Pharma, Inc.
    February 9, 2026
  • SpyGlass Pharma Announces Pricing of Initial Public Offering

    SpyGlass Pharma, Inc.
    February 7, 2026